Currently, in France, the pap-smear test is the reference in prevention for cervical neoplasia (CIN) and cancer screening. Screening and treatment allowed to reduce the incidence and the mortality by cervical cancer by half, since the two last decades. But many women are still not reached by prevention programs, especially precarious women. In 2013, Doctors of the World France evaluated that almost 70% of women aged from 25 to 65 years coming in its medical center had never benefit of a pap-smear test.